Skip to content

Retrospective study of Clinical utility(included pain evaluation) by monthly minodronic acid hydrate for Osteoporosis.

Retrospective study of Clinical utility(included pain evaluation) by monthly minodronic acid hydrate for Osteoporosis. - Retrospective study of Clinical utility by monthly minodronic acid hydrate for Osteoporosis.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000009959
Enrollment
120
Registered
2013-02-05
Start date
2013-02-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoporosis

Interventions

None listed

Sponsors

Yoshida Orthopedics Clinic
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1.The patient who has been newly diagnosed as osteoporosis from Oct.2011 to July 2012, with carried MIN-M medical treatment. 2.The patients whose pain VAS score at the time of a MIN-M medication start was four or more.

Exclusion criteria

Exclusion criteria: 1.The patient who offered refused. 2.Investigator judged to be unsuitable as an object of this study.

Design outcomes

Primary

MeasureTime frame
Low back pain by VAS-Scale Change of bone turnover markers Change of bone mineral density

Countries

Japan

Contacts

Public ContactAkira Yoshida

Yoshida Orthopedics Clinic Orthopedic Surgery

+81-139-42-5770

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026